10.55  -0.19 (-1.77%)		03-16 16:00
Open: 11.03 High: 11.03 Volume: 13,773		Pre. Close: 10.74 Low: 10.41 Market Cap: 334(M)

Short term
Mid term
Targets	6-month :	14.4	1-year :	16.44
Resists	First :	12.33	Second :	14.07
Pivot price	10.79
Supports	First :	9.5	Second :	7.9
MAs	MA(5) :	11.02	MA(20) :	10.76
	MA(100) :	10.61	MA(250) :	10.46
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	27.5	D(3) :	29.5
RSI	RSI(14): 45.7
52-week	High :	14.07	Low :	9.5

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ VACH ] has closed above bottom band by 33.9%. Bollinger Bands are 1094.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	11.04 - 11.13	11.13 - 11.19
Low:	10.23 - 10.33	10.33 - 10.39
Close:	10.42 - 10.57	10.57 - 10.67

Voyager Acquisition Corp. is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. The company has not selected any specific business combination target and has not initiated any substantive discussions with potential targets.

Fri, 13 Mar 2026
Voyager Acquisition Corp. Secures Shareholder Approval for VERAXA Biotech Merger - citybiz

Fri, 13 Mar 2026
Voyager Acquisition Corp files for IPO of 22,000,000 units for $220 million - marketscreener.com

Fri, 13 Mar 2026
SPAC investors cash out, leaving $885K and 82,685 shares in VERAXA deal - Stock Titan

Wed, 11 Mar 2026
25M Voyager shares redeemed, leaving 82,685 for VERAXA deal - Stock Titan

Tue, 10 Mar 2026
Voyager Acquisition 10-K: Revenue $0.01M, EPS $0.28 - TradingView

Tue, 03 Mar 2026
VERAXA Biotech Receives 99.57% Approval for Merger - Path to NASDAQ Listing Under «VRXA» Cleared - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	25 (M)
Shares Float	21 (M)
Held by Insiders	28.6 (%)
Held by Institutions	109 (%)
Shares Short	5 (K)
Shares Short P.Month	8 (K)

EPS	0.3
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.39
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	11.1 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	35.16
PEG Ratio	0
Price to Book value	-27.06
Price to Sales	0
Price to Cash Flow	-527.98

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.